Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01009931 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01009931: Clinical Trial Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
NCT01009931 is a Phase 2 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01009931, a Phase 2 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This phase II trial is studying the side effects and how well giving tetradecanoylphorbol acetate together with dexamethasone and choline magnesium trisalicylate works in treating patients with relapsed or refractory acute myeloid leukemia.
Interventions
- DRUG Dexamethasone
- DRUG 12-O-tetradecanoylphorbol-13-acetate
- DRUG Choline magnesium trisalicylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Why NCT01009931 stopped before completion
NCT01009931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Dexamethasone is the first listed.
NCT01009931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01009931 about?
NCT01009931 is a clinical study titled "Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies". This phase II trial is studying the side effects and how well giving tetradecanoylphorbol acetate together with dexamethasone and choline magnesium trisalicylate works in treating patients with relapsed or refractory acute myeloid leukemia.
What is the current status of trial NCT01009931?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2011-03. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01009931?
The interventions under investigation include: Dexamethasone (DRUG), 12-O-tetradecanoylphorbol-13-acetate (DRUG), Choline magnesium trisalicylate (DRUG).
Who is sponsoring clinical trial NCT01009931?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01009931's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia